The Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland

The Sidney Kimmel Comprehensive Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21205.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

The Sidney Kimmel Comprehensive Cancer Center has participated in 17 clinical trials with 3 currently active.

Therapeutic areas: Prostate Neoplasms, Hepatocellular Carcinoma, Multiple Myeloma.

Sponsors: Astellas Pharma Inc, Tvardi Therapeutics, Incorporated, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Baltimore

Browse all research sites in Maryland · View every site in Baltimore

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Sidney Kimmel Comprehensive Cancer Center?

The Sidney Kimmel Comprehensive Cancer Center has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Sidney Kimmel Comprehensive Cancer Center conducted?

The Sidney Kimmel Comprehensive Cancer Center has 17 clinical trials on record, with 3 currently active. Their work covers Prostate Neoplasms, Hepatocellular Carcinoma, Multiple Myeloma.

Is The Sidney Kimmel Comprehensive Cancer Center accredited by Crixeo Clinical Trials?

The Sidney Kimmel Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Sidney Kimmel Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.